Drug Profile
Research programme: glucocorticoid receptor agonists - AstraZeneca/Bayer Schering Pharma
Alternative Names: SEGRAs - AstraZeneca/Bayer Schering Pharma; WC 3027Latest Information Update: 24 Mar 2010
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma
- Developer AstraZeneca; Warner Chilcott
- Class Glucocorticoids
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Respiratory tract disorders